We noted that increased expression of LTR66-POU5F1B in the SYSCOL cohort coincided with the transition from normal tissue to adenoma and from adenoma to carcinoma (Fig. 1c), which strongly suggested that LTR66-POU5F1B was a marker of advanced disease. This evidence concerns the gene POU5F1B and carcinoma.